Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
6(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
2
17%
Ph not_applicable
1
8%
Ph phase_2
9
75%

Phase Distribution

0

Early Stage

9

Mid Stage

2

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
9(75.0%)
Phase 3Large-scale testing
2(16.7%)
N/ANon-phased studies
1(8.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

6

trials recruiting

Total Trials

12

all time

Status Distribution
Active(9)
Completed(2)
Other(1)

Detailed Status

Recruiting5
Not yet recruiting3
Completed2
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
6
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 29 (75.0%)
Phase 32 (16.7%)
N/A1 (8.3%)

Trials by Status

active_not_recruiting18%
unknown18%
not_yet_recruiting325%
recruiting542%
completed217%

Recent Activity

Clinical Trials (12)

Showing 12 of 12 trials
NCT06204094Phase 2

Node-sparing Radiotherapy Combined With Total Neoadjuvant CAPOX and Sintilimab for MSS Middle and Low Rectal Cancer

Recruiting
NCT07239466Phase 2

A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer

Recruiting
NCT05673772Phase 2

Preoperative Sequential Short-course Radiation Therapy and FOLFOX for Locally Advanced Rectal Cancer

Active Not Recruiting
NCT07113275Phase 3

A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in High-Risk Locally Advanced Rectal Cancer

Not Yet Recruiting
NCT06493240Phase 2

Neoadjuvant Long-course Chemoradiotherapy Followed by Immunotherapy for Locally Advanced Mid-low Rectal Cancer

Completed
NCT07243938Phase 2

Phase II Basket Trial: Zanidatamab Plus Tislelizumab in HER2-Positive GI Tumors (UNION-HER2-BASKET)

Not Yet Recruiting
NCT05576480Phase 2

SCRT Sequential Penpulimab in Combination With CAPEOX in the Neoadjuvant Treatment of MSS Locally Advanced Rectal Cancer

Recruiting
NCT07057089Phase 2

Involved-field Radiotherapy-TNT Combined With PD-1 Inhibitor for pMMR Locally Advanced Rectal Cancer (Neo-Field I)

Recruiting
NCT01804790Phase 3

Efficacy of Neoadjuvant Folfirinox Regimen in Patients With Resectable Locally Advanced Rectal Cancer

Completed
NCT06802666Phase 2

Short-course Radiotherapy Followed by AK112 and CAPOX as Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Recruiting
NCT05794750Phase 2

Assess the Efficacy of Radiotherapy and Sequential Chemotherapy and AK104 Before TME Surgery for Local CRC(AK104-IIT-13)

Not Yet Recruiting
NCT02498353Not Applicable

Comparing Preoperative Short-course Radiotherapy With or Without Local Boost for Rectal Cancer

Unknown

All 12 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
12